Illumina Inc (ILMN.O)
ILMN.O on Nasdaq
344.00USD
14 Jun 2019
344.00USD
14 Jun 2019
Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$344.00
$344.00
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
472
472
Avg. Vol
905,919
905,919
52-wk High
$372.61
$372.61
52-wk Low
$268.62
$268.62
About
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of... (more)
Overall
| Beta: | 1.08 |
| Market Cap(Mil.): | $50,568.00 |
| Shares Outstanding(Mil.): | 147.00 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ILMN.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 59.65 | 107.36 | 37.45 |
| EPS (TTM): | 5.77 | -- | -- |
| ROI: | 16.22 | 5.83 | 12.16 |
| ROE: | 24.65 | 8.20 | 16.93 |
Genome data co BGI escalates Illumina patent feud with Delaware complaint
BGI Group, a genome sequencing company based in China, on Monday escalated its global intellectual property fight with rival Illumina Inc by filing a U.S. patent case against the California-based firm.
Estimates